Literature DB >> 19141618

Aldosterone increases oxidant stress to impair guanylyl cyclase activity by cysteinyl thiol oxidation in vascular smooth muscle cells.

Bradley A Maron1, Ying-Yi Zhang, Diane E Handy, Annie Beuve, Shiow-Shih Tang, Joseph Loscalzo, Jane A Leopold.   

Abstract

Hyperaldosteronism is associated with impaired endothelium-dependent vascular reactivity owing to increased reactive oxygen species and decreased bioavailable nitric oxide (NO(.)); however, the effects of aldosterone on vasodilatory signaling pathways in vascular smooth muscle cells (VSMC) remain unknown. Soluble guanylyl cyclase (GC) is a heterodimer that is activated by NO(.) to convert cytosolic GTP to cGMP, a second messenger required for normal VSMC relaxation. Here, we show that aldosterone (10(-9)-10(-7) mol/liter) diminishes GC activity by activating NADPH oxidase in bovine aortic VSMC to increase reactive oxygen species levels and induce oxidative posttranslational modification(s) of Cys-122, a beta(1)-subunit cysteinyl residue demonstrated previously to modulate NO(.) sensing by GC. In VSMC treated with aldosterone, Western immunoblotting detected evidence of GC beta(1)-subunit disulfide bonding, whereas mass spectrometry analysis of a homologous peptide containing the Cys-122-bearing sequence exposed to conditions of increased oxidant stress confirmed cysteinyl sulfinic acid (m/z 435), sulfonic acid (m/z 443), and disulfide (m/z 836) bond formation. The functional effect of these modifications was examined by transfecting COS-7 cells with wild-type GC or mutant GC containing an alanine substitution at Cys-122 (C122A). Exposure to aldosterone or hydrogen peroxide (H(2)O(2)) significantly decreased cGMP levels in cells expressing wild-type GC. In contrast, aldosterone or H(2)O(2) did not influence cGMP levels in cells expressing the mutant C122A GC, confirming that oxidative modification of Cys-122 specifically impairs GC activity. These findings demonstrate that pathophysiologically relevant concentrations of aldosterone increase oxidant stress to convert GC to an NO(.)-insensitive state, resulting in disruption of normal vasodilatory signaling pathways in VSMC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19141618      PMCID: PMC2658060          DOI: 10.1074/jbc.M809460200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

Review 1.  Studying the structure and regulation of soluble guanylyl cyclase.

Authors:  D Koesling
Journal:  Methods       Date:  1999-12       Impact factor: 3.608

Review 2.  Aldosterone in congestive heart failure.

Authors:  K T Weber
Journal:  N Engl J Med       Date:  2001-12-06       Impact factor: 91.245

Review 3.  Aldosteronism revisited: perspectives on less well-recognized actions of aldosterone.

Authors:  Karl T Weber
Journal:  J Lab Clin Med       Date:  2003-08

4.  Aldosterone-induced inflammation in the rat heart : role of oxidative stress.

Authors:  Yao Sun; Jiakun Zhang; Li Lu; Sue S Chen; Mark T Quinn; Karl T Weber
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

5.  The effect of peroxynitrite on the catalytic activity of soluble guanylyl cyclase.

Authors:  M Weber; N Lauer; A Mülsch; G Kojda
Journal:  Free Radic Biol Med       Date:  2001-12-01       Impact factor: 7.376

6.  Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure.

Authors:  C A Farquharson; A D Struthers
Journal:  Circulation       Date:  2000-02-15       Impact factor: 29.690

7.  Hypoxia potentiates nitric oxide-mediated apoptosis in endothelial cells via peroxynitrite-induced activation of mitochondria-dependent and -independent pathways.

Authors:  Geoffrey A Walford; Rose-Laure Moussignac; Anne W Scribner; Joseph Loscalzo; Jane A Leopold
Journal:  J Biol Chem       Date:  2003-11-03       Impact factor: 5.157

8.  Reversible inactivation of guanylate cyclase by mixed disulfide formation.

Authors:  H J Brandwein; J A Lewicki; F Murad
Journal:  J Biol Chem       Date:  1981-03-25       Impact factor: 5.157

9.  A FRET-based method to study protein thiol oxidation in histological preparations.

Authors:  Pier G Mastroberardino; Adam L Orr; Xiaoping Hu; Hye Mee Na; J Timothy Greenamyre
Journal:  Free Radic Biol Med       Date:  2008-06-27       Impact factor: 7.376

Review 10.  Aldosterone-induced vasculopathy.

Authors:  Allan D Struthers
Journal:  Mol Cell Endocrinol       Date:  2004-03-31       Impact factor: 4.102

View more
  42 in total

1.  Structural and functional insights into the heme-binding domain of the human soluble guanylate cyclase α2 subunit and heterodimeric α2β1.

Authors:  Hongyan Wang; Fangfang Zhong; Jie Pan; Wei Li; Jihu Su; Zhong-Xian Huang; Xiangshi Tan
Journal:  J Biol Inorg Chem       Date:  2012-03-18       Impact factor: 3.358

Review 2.  S-nitrosothiols and the S-nitrosoproteome of the cardiovascular system.

Authors:  Bradley A Maron; Shiow-Shih Tang; Joseph Loscalzo
Journal:  Antioxid Redox Signal       Date:  2012-09-05       Impact factor: 8.401

Review 3.  Thiol-Based Redox Modulation of Soluble Guanylyl Cyclase, the Nitric Oxide Receptor.

Authors:  Annie Beuve
Journal:  Antioxid Redox Signal       Date:  2016-04-01       Impact factor: 8.401

Review 4.  Mineralocorticoid receptors in vascular function and disease.

Authors:  Amy McCurley; Iris Z Jaffe
Journal:  Mol Cell Endocrinol       Date:  2011-06-24       Impact factor: 4.102

5.  Redox Pioneer: Professor Joseph Loscalzo.

Authors:  Jane A Leopold
Journal:  Antioxid Redox Signal       Date:  2010-10-01       Impact factor: 8.401

6.  Heme-assisted S-nitrosation desensitizes ferric soluble guanylate cyclase to nitric oxide.

Authors:  Nathaniel B Fernhoff; Emily R Derbyshire; Eric S Underbakke; Michael A Marletta
Journal:  J Biol Chem       Date:  2012-10-23       Impact factor: 5.157

7.  A nitric oxide/cysteine interaction mediates the activation of soluble guanylate cyclase.

Authors:  Nathaniel B Fernhoff; Emily R Derbyshire; Michael A Marletta
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-09       Impact factor: 11.205

Review 8.  Impact of glucose-6-phosphate dehydrogenase deficiency on the pathophysiology of cardiovascular disease.

Authors:  Peter A Hecker; Jane A Leopold; Sachin A Gupte; Fabio A Recchia; William C Stanley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-12-15       Impact factor: 4.733

Review 9.  Responses to reductive stress in the cardiovascular system.

Authors:  Diane E Handy; Joseph Loscalzo
Journal:  Free Radic Biol Med       Date:  2016-12-08       Impact factor: 7.376

Review 10.  Direct contribution of vascular mineralocorticoid receptors to blood pressure regulation.

Authors:  Kathleen V Barrett; Amy T McCurley; Iris Z Jaffe
Journal:  Clin Exp Pharmacol Physiol       Date:  2013-12       Impact factor: 2.557

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.